NIFTY23,4060.33%
SENSEX74,3460.41%
BANKNIFTY54,1860.88%
NIFTY IT29,3845.57%
PHARMA24,0870.33%
AUTO26,0930.05%
FMCG48,1241.01%
METAL13,5350.17%
REALTY762.601.39%
ENERGY40,1970.02%
NIFTY23,4060.33%
SENSEX74,3460.41%
BANKNIFTY54,1860.88%
NIFTY IT29,3845.57%
PHARMA24,0870.33%
AUTO26,0930.05%
FMCG48,1241.01%
METAL13,5350.17%
REALTY762.601.39%
ENERGY40,1970.02%

Financial Report

March 16, 2024

Industry Body Flags Concerns to RBI

The PHDCCI (Pharmaceuticals Export Promotion Council of India) has met with RBI Governor Sanjay Malhotra to discuss several key issues impacting the industry. The main concerns raised by the industry body include inconsistent treatment of discrepancies in Letter of Credit (LC) documents by issuing banks and unfair trade practices by rating agencies.

Read also: Treasury Yields Experience Largest Increase in Two Weeks Following Release of Labor Market Data

Letter of Credit Discrepancies

The PHDCCI has highlighted the issue of banks refusing payment even when discrepancies are minor and have been formally waived by the LC applicant. This inconsistent treatment creates uncertainty for suppliers and exporters, undermining the reliability of Letters of Credit as payment instruments. The industry body has requested the RBI to issue clear operational guidelines requiring banks to honor LC documents where discrepancies have been formally waived by the applicant, except in cases involving fraud or material risk.

Credit to MSMEs

The PHDCCI has also called for an increase in the credit to MSMEs through NBFCs limit. The RBI has restored the classification of credit to MSMEs through NBFCs under priority sector but only up to Rs 20 lakh a borrower. With the revision in classification criteria of MSMEs announced in the budget 2025, almost 99 percent of enterprises are now MSMEs, with their turnover limit increasing up to Rs 500 crore. The industry body has requested the RBI to remove the Rs 20 lakh loan limit or increase it to at least Rs 1 crore per borrower.

Read also: US-Iran Tensions Spark Uptick in Oil Prices Amid Global Market Decline

Digitalisation and Documentation

The PHDCCI has also requested the RBI to look at introducing uniformity and digitalisation in documentation, which it said is hindering the smooth functioning of the industry. Additionally, the industry body has flagged unfair trade practices by rating agencies, including demanding rating fees for future even when the rating is not required.

Recommendations

The PHDCCI has made several recommendations to the RBI, including:

  • Issuing clear operational guidelines for banks to honor LC documents where discrepancies have been formally waived by the applicant
  • Prescribing uniform procedures and standardized documentation practices for discrepancy waivers
  • Treating credit given by banks to NBFCs for on-lending to MSMEs as indirect finance to MSMEs eligible for classification under priority sector lending
  • Removing the Rs 20 lakh loan limit or increasing it to at least Rs 1 crore per borrower
  • Introducing uniformity and digitalisation in documentation
  • Stopping unfair trade practices by rating agencies, including demanding rating fees for future even when the rating is not required.

Investor Takeaway

Investors should be aware of potential disruptions in MSME lending due to inconsistent Letter of Credit rules.

IPOScanner Logo

IPOScanner helps investors track upcoming, live and past IPOs in one place with GMP, subscription, allotment status and listing performance insights.

About IPO Scanner

IPOScanner is built for investors who want a clear view of every IPO opportunity in one place. From upcoming issues to live subscription data, allotment updates and listing performance, we bring together the key details you need to track the primary market.

Our tools are designed to be simple, fast and investor-friendly so you can focus on evaluating businesses instead of opening multiple tabs and websites for basic information.

Details of client bank account
For any query / feedback / clarifications, email at
[email protected].

Please read all offer documents and risk disclosures carefully before investing. IPOScanner does not provide investment advice and information on this site should not be treated as a recommendation to apply for any IPO.

© 2026 IPO Scanner. All rights reserved.